Perrigo

How High Can A Premium Get? The Mylan – Meda Case

Mylan N.V.; market cap as of 12/02/2016: $20.54bn Meda AB; market cap as of 12/02/2016: kr52.44bn ($6.24bn) Introduction On February 10, Mylan NV (NASDAQ: MYL.O) announced its acquisition of Meda AB (STO: MEDAa.ST) in a deal worth $7.2bn made of cash and stock, while the latter reported an unexpected slowdown Read more…

By BSIC, 11 years13 February 2016 ago

Corporate Finance Debt Deals Equity Deals M&A Deals Old Articles

Teva and Mylan : The Plot Thickens…

Teva Pharmaceutical Industries ; Market Cap (as of 25/04/2015): $62,67bn Mylan Pharmaceuticals ; Market Cap (as of 25/04/2015): $36,06bn Introduction In the healthcare industry, the saying “eat or be eaten” no longer applies. Instead, the adage of “make a bid or wait for an offer” would be more appropriate Read more…

By BSIC, 11 years25 April 2015 ago

How High Can A Premium Get? The Mylan – Meda Case

Teva and Mylan : The Plot Thickens…

bsic_official